(NASDAQ: MEDP) Medpace Holdings's forecast annual revenue growth rate of 6.79% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Medpace Holdings's revenue in 2025 is $2,109,054,000.On average, 5 Wall Street analysts forecast MEDP's revenue for 2025 to be $65,304,745,590, with the lowest MEDP revenue forecast at $64,315,427,466, and the highest MEDP revenue forecast at $65,805,254,279. On average, 5 Wall Street analysts forecast MEDP's revenue for 2026 to be $71,164,030,320, with the lowest MEDP revenue forecast at $68,663,040,682, and the highest MEDP revenue forecast at $73,437,189,182.
In 2027, MEDP is forecast to generate $78,553,327,580 in revenue, with the lowest revenue forecast at $75,201,217,250 and the highest revenue forecast at $81,200,131,351.